• 1. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 2. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Fe3O4/FeS2 heterostructures enable efficient oxygen evolution reaction?
  Xingqun Zheng,Lele Song,Xin Feng,Li Li,Zidong Wei J. Mater. Chem. A, 2020,8, 14145-14151

Research Brief on Tert-butyl 6-amino-2-(oxan-4-yl)hexanoate (CAS: 2137563-67-6) in Chemical Biology and Pharmaceutical Applications

The compound Tert-butyl 6-amino-2-(oxan-4-yl)hexanoate (CAS: 2137563-67-6) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique structural features including a tert-butyl ester and a tetrahydropyran (oxane) ring, serves as a versatile intermediate in the synthesis of bioactive molecules. Recent studies have highlighted its potential in drug discovery, particularly in the development of protease inhibitors and modulators of protein-protein interactions. The presence of both amino and ester functional groups allows for further derivatization, making it a valuable scaffold for medicinal chemistry.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers explored the use of Tert-butyl 6-amino-2-(oxan-4-yl)hexanoate as a key intermediate in the synthesis of novel cysteine protease inhibitors. The study demonstrated that derivatives of this compound exhibited potent inhibitory activity against cathepsin B, a protease implicated in cancer metastasis and inflammatory diseases. The researchers employed a combination of molecular docking and kinetic assays to elucidate the binding modes of these derivatives, revealing that the oxan-4-yl moiety contributes significantly to the stabilization of the enzyme-inhibitor complex. These findings underscore the potential of this scaffold in designing next-generation protease inhibitors.

Another notable application of Tert-butyl 6-amino-2-(oxan-4-yl)hexanoate was reported in a recent Bioorganic & Medicinal Chemistry Letters article, where it was utilized as a building block for the development of small-molecule modulators of the Keap1-Nrf2 pathway. This pathway plays a critical role in cellular defense against oxidative stress, and its dysregulation is associated with various neurodegenerative and inflammatory conditions. The study showcased the compound's ability to serve as a flexible linker, enabling the synthesis of structurally diverse analogs with enhanced binding affinity to Keap1. The optimized analogs demonstrated promising activity in vitro, suggesting their potential as therapeutic agents for oxidative stress-related disorders.

From a synthetic chemistry perspective, Tert-butyl 6-amino-2-(oxan-4-yl)hexanoate has also been employed in the construction of peptidomimetics and macrocyclic compounds. A 2022 study in Organic Letters detailed an efficient asymmetric synthesis route for this compound, leveraging chiral auxiliaries to achieve high enantiomeric purity. The researchers emphasized the scalability of this method, which is crucial for its industrial application in drug development. Furthermore, the compound's stability under various reaction conditions makes it an attractive candidate for multi-step synthetic transformations.

In conclusion, Tert-butyl 6-amino-2-(oxan-4-yl)hexanoate (CAS: 2137563-67-6) represents a multifaceted tool in modern drug discovery and chemical biology. Its applications span from protease inhibition to oxidative stress modulation, supported by robust synthetic methodologies. Future research directions may include the exploration of its utility in targeted drug delivery systems and the development of bifunctional molecules that leverage its unique structural features. As the field continues to evolve, this compound is poised to play a pivotal role in addressing unmet medical needs through innovative chemical strategies.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)